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Abstract
Background: Kainic acid (KA)-induced status epilepticus (SE) was involved with release of free radicals. Sesamin is a
well-known antioxidant from sesame seeds and it scavenges free radicals in several brain injury models. However
the neuroprotective mechanism of sesamin to KA-induced seizure has not been studied.
Methods: Rodents (male FVB mice and Sprague-Dawley rats) were fed with sesamin extract (90% of sesamin and
10% sesamolin), 15 mg/kg or 30 mg/kg, for 3 days before KA subcutaneous injection. The effect of sesamin on KA-
induced cell injury was also investigated on several cellular pathways including neuronal plasticity (RhoA),
neurodegeneration (Caspase-3), and inflammation (COX-2) in PC12 cells and microglial BV-2 cells.
Results: Treatment with sesamin extract (30 mg/kg) significantly increased plasma a-tocopherol level 50% and
55.8% from rats without and with KA treatment, respectively. It also decreased malondialdehyde (MDA) from 145%
to 117% (p = 0.017) and preserved superoxide dismutase from 55% of the vehicle control mice to 81% of sesamin-
treated mice, respectively to the normal levels (p = 0.013). The treatment significantly decreased the mortality from
22% to 0% in rats. Sesamin was effective to protect PC12 cells and BV-2 cells from KA-injury in a dose-dependent
manner. It decreased the release of Ca
2+, reactive oxygen species, and MDA from PC12 cells. Western blot analysis
revealed that sesamin significantly reduced ERK1/2, p38 mitogen-activated protein kinases, Caspase-3, and COX-2
expression in both cells and RhoA expression in BV-2 cells. Furthermore, Sesamin was able to reduce PGE2
production from both cells under KA-stimulation.
Conclusions: Taken together, it suggests that sesamin could protect KA-induced brain injury through anti-
inflammatory and partially antioxidative mechanisms.
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Background
Status epilepticus (SE) is defined as a period of continu-
ous seizure activity [1,2]. Prolonged febrile seizures and
SE have been implicated as a major predisposing factor
for the development of mesial temporal sclerosis and
temporal lobe epilepsy [1,3]. This emergency condition
requires a prompt and appropriate treatment to prevent
brain damage and eventual death. In animal models,
similar pathologic changes can be observed with electri-
cally and chemically induced seizures [4-7]. Animal stu-
dies show that SE causes recurrent spontaneous seizures
(epilepsy) [6,8,9] and releases free radicals from experi-
mental models of kainic acid (KA), pilocarpine, pentyle-
netetrazole, and ferric chloride [10-14].
KA, a glutamate related chemical, induces neuronal
excitability, reactive oxygen species (ROS) production
and lipid peroxidation in neurons [15-17]. It triggers
neuronal membrane depolarization by the release of cal-
cium ions which are involved in nerve impulse
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any medium, provided the original work is properly cited.transmission as the calcium action potential reaches the
synapse [15]. The apoptosis of nerve cells can be trig-
gered by a large number of intracellular calcium influx
[18]. Mitogen-activated protein kinases (MAPKs) and
Rho kinases are also associated with seizures, inflamma-
tion and apoptosis [19-21].
Sesamin and sesamolin are the major lignans from
sesame seeds. Previously, we and others report that
sesamin can protect against hypoxia-, H2 O2 -or 1-
methyl-4-phenyl-pyridine (MPP
+)-induced brain and
PC12 cells injuries [22,23]. Various plant antioxidants
have been shown to protect brain form KA-induced
calcium ions and ROS [24-26]. Sesamin also inhibits
nitric oxide (NO) and cytokine production in lipopoly-
saccharide (LPS)-and oxidative-stressed BV-2 microglia
[27,28].
It is perceivable that sesamin could protect animal
from KA-induced SE as in other brain injury models.
Therefore, this study investigated the effect of sesamin
on the KA-induced SE animals as well as the protective
mechanism in neuronal PC12 cells and microglial BV-2
cells.
Methods
Reagents
Pure sesamin and sesamin extract (90% sesamin and
10% sesamolin, as determined by HPLC) were purchased
from Joben Bio-medical co. (Kaohsiung, Taiwan). Kainic
acid (KA) was obtained from Sigma-Aldrich (Steinheim,
Germany) and Cayman Chemical (Ann Arbor, MI,
USA), 2’,7 ’-dichlorodihydrofluorescein diacetate (H2
DCF-DA) was obtained from Molecular Probes (Eugene,
OR, USA).
Oxidative Stress in mice
Adult male FVB mice, 23-25 g of weight, were used for
the study. SE was induced with KA (30 mg/ml in phos-
phate-buffered saline (PBS), 30 mg/kg, s.c.). Sesamin
extract was diluted with corn oil (30 mg/ml). The ani-
mals were fed with 2 different dosages of sesamin
extract (15 mg/kg or 30 mg/kg) by gavage for 3 days
before the KA experiment. The vehicle control group
was fed with equal volume of corn oil. The procedures
were approved by the Institutional Animal Care and Use
Committee, Taichung Veterans General Hospital
(IACUC Approval No. LA-97490) and all possible steps
were taken to avoid animals’ suffering at each stage of
experiments.
Diazepam at lethal dosage, 60 mg/kg i.p., was given to
stop seizures 2 h after KA injection and the animal was
sacrificed by decapitation under CO2 asphyxia. The
naïve animal serves as a control. The whole brain was
removed and immediately frozen in liquid nitrogen and
stored at-70°C until use.
Malondialdehyde (MDA) as a part of thiobarbituric
acid reacting substances (TBARS) was used as an indica-
tor of lipid peroxidation. To estimate oxidative stress,
the amount of TBARS in the brain from each group was
measured. Manual homogenization of brains was carried
out at 4°C with a cold buffer. Protein concentration of
the homogenate was determined by BCA protein assay
using bovine serum albumin as a standard. The detec-
tion of TBARS was from the modified method of
Ohkawa [29]. Briefly, the sample (0.2 ml) was mixed
with the same volume of 20% (w/v) trichloroacetic acid
and 1% (w/v) thiobarbituric acid in 0.3% (w/v) NaOH.
The mixture was heated in the water bath at 95°C for
40 min, cooled to room temperature and centrifugation
at 5000 rpm for 5 min at 4°C. The fluorescence of the
supernatant was determined by a spectrophotometer
with excitation at 544 nm and emission at 590 nm.
Superoxide dismutase (SOD) activity was determined
by a RANSOD kit (Randox, USA). This method was
based on the formation of red formazan from the reac-
tion of 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenylte-
trazolium chloride and superoxide radical and assayed
in a spectrophotometer at 505 nm. The inhibition of the
produced chromogen was proportional to the activity of
the SOD present in the sample. A 50% inhibition was
defined as one unit of SOD, and specific activity was
expressed as units per milligram protein.
Measurement of tocopherols
Plasma a-tocopherol was determined by HPLC method.
Briefly, plasma was treated with anti-oxidant reagent
(0.25% BHT and 0.2% vitamin C in methanol, 1:7),
mixed and centrifuged for 10 min × 12000 g.S a m p l e
(20 μl) or internal control was then injected to HPLC
s y s t e m( B A SP M - 8 0 )w i t hC 1 8c o l u m n( 4 . 6×1 5 0m m ,
5 μm; mobile phase, 95% methanol, flow rate: 1.0 ml/
min) and fluorescence detector with 296 nm excitation,
and 340 nm emission.
Mortality and behavior
Adult male Sprague-Dawley rats weighing 380-420 g
were used to study the protective effect of sesamin
extract. Rats were fed with sesamin extract (30 mg/kg/
day) for 3 days before the SE experiment. The control
group was treated with the vehicle corn oil. SE was
induced with kainic acid (12 mg/kg, in PBS, s.c.). Each
behavioral seizure was recorded according to a modified
classification from Racine [30]: 0, immobility or explor-
ing; 1, facial clonus; 2, head nodding; 3, unilateral fore-
limb clonus; 4, bilateral forelimb clonus and rearing; 5,
falling; 6, repeated falling; 7, bouncing; 8, generalized
tonus. Four behavioral patterns of SE could be recog-
nized: immobile (class 0), exploratory (class 0), mastica-
tory (class 1-2) and clonic (class 3-8) [31]. Diazepam, 25
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the 10-h mortality rate was recorded.
Cell culture
Rat pheochromacytoma (PC12) cells and murine micro-
glial BV-2 cells were maintained in Dulbecco’sm o d i f i e d
Eagle’s medium (DMEM) supplemented with 10% fetal
bovine serum (FBS), 5% heat-inactivated horse serum,
100 U/ml penicillin and 100 μg/ml streptomycin at 37°C
in a humidified incubator under 5% CO2. Confluent cul-
tures were passaged by trypsinization. For experiments,
cells were washed twice with warm DMEM (without
phenol red), then treated in serum-free medium. In all
experiments, cells were treated with and without sesa-
min and/or KA-stress for the indicated times.
Cell viability
Cell viability was measured with blue formazan that was
metabolized from colorless 3-(4,5-dimethyl-thiazol-2-yl)-
2,5-diphenyl tetrazolium bromide (MTT) by mitochon-
drial dehydrogenases, which are active only in live cells.
PC12 cells were pre-incubated in 24-well plates at a
density of 5 × 10
5 cells per well for 24 h, and then
washed with PBS. Cells with various concentrations of
sesamin were treated with 150 mM KA for 24 h, and
g r o w ni n0 . 5m g / m lM T Ta t3 7 ° C .O n eh o u rl a t e r ,2 0 0
μl of solubilization solution was added to each well and
absorption values read at 540 nm on an automated
spectraMAX 340 (Molecular Devices, Sunnyvale, CA,
USA) microtiter plate reader. Data were expressed as
the mean percent of viable cells vs. control.
Lactate dehydrogenase (LDH) release assay
Cytotoxicity was determined by measuring the release of
LDH. PC12 cells or BV-2 cells with various concentra-
tions of sesamin were treated with 150 mM KA for 24
h and the supernatant was used to assay LDH activity.
The reaction was initiated by mixing 0.1 ml of cell-free
supernatant with potassium phosphate buffer containing
nicotinamide adenine dinucleotide (NADH) and sodium
pyruvate in a final volume of 0.2 ml to 96-well plate.
The rate of absorbance was read at 490/630 nm on a
spectraMAX 340 instrument. Data were expressed as
the mean percent of viable cells vs. 150 mM KA
control.
Calcium release
PC12 cells or BV-2 cells with various concentrations of
sesamin were treated with 150 mM KA for 24 h and the
supernatant was used to assay the release of Ca
2+.T h e
10 μl supernatant was added to 1 ml Ca
2+ reagent
(Diagnostic Systems, Holzheim, Germany) and mixed
well, stood for 5 min, then transferred the 100 μl aliquot
to 96 well. The calcium concentration was determined
using a microplate reader with a 620 nm absorbance
and quantified with a 10 mg/ml Ca
2+ standard solution.
Reactive oxygen species generation
Intracellular accumulation of ROS was determined with
H2 DCF-DA. This nonfluorescent compound accumu-
lates within cells upon deacetylation. H2 DCF then
reacts with ROS to form fluorescent dichlorofluorescein
(DCF). PC12 cells or BV-2 cells were plated in 96-well
plates and grown for 24 h before addition of DMEM
plus 10 μMH 2 DCF-DA, incubation for 60 min at 37°C,
and treatment with 150 μM KA for 60 or 120 min. Cells
were then washed twice with room temperature Hank’s
balanced salt solution (HBSS without phenol red). Cellu-
lar fluorescence was monitored on a Fluoroskan Ascent
fluorometer (Labsystems Oy, Helsinki, Finland) using an
excitation wavelength of 485 nm and emission wave-
length of 538 nm.
Measurement of lipid peroxidation
Lipid peroxidation is quantified by measuring malondial-
dehyde (MDA) of PC12 cells by lipid peroxidation
(LPO) assay kit (Cayman Chemical, Ann Arbor, MI,
USA). This kit works on the principle of condensation
of one molecule of either MDA or 4-hydroxyalkenals
with two molecules of N-methyl-2-phenylindole to yield
a stable chromophore. MDA levels were assayed by
measuring the amount expressed in 5 × 10
5 cells and
the absorbance at 500 nm was determined using an
ELISA reader (spectraMAX 340).
Preparation of cell extracts
Test medium was removed from culture dishes and cells
were washed twice with ice-cold PBS, scraped off with a
rubber policeman, and centrifuged at 200 × g for 10 min
at 4°C. The cell pellets were resuspended in an appropriate
volume (~4 × 10
7 cells/ml) of lysis buffer containing 20
mM Tris-HCl, pH 7.5, 137 mM NaCl, 1 mM phenyl-
methylsulfonylfluoride, 10 μg/ml aprotinin, 10 μg/ml leu-
peptin, and 5 μg/ml pepstain A. The suspension was then
sonicated. Protein concentration of samples was deter-
mined by Bradford assay (Bio-Rad, Hemel, Hempstead,
UK) and samples equilibrated to 2 mg/ml with lysis buffer.
Western blotting
Protein samples from PC12 cells or BV-2 cells contain-
ing 50 μg of protein were separated on 12% sodium
dodecyl sulfate-polyacrylamide gels and transferred to
immobile polyvinylidene difluoride membranes (Milli-
pore, Bedford, MA). Membranes were incubated for 1 h
with 5% dry skim milk in TBST buffer (0.1 M Tris-HCl,
pH 7.4, 0.9% NaCl, 0.1% Tween-20) to block nonspecific
binding, and then incubated with rabbit anti-COX-2,
Rho A (1:1000; Cayman chemical; Cell Signaling, USA),
Hsieh et al. Journal of Neuroinflammation 2011, 8:57
http://www.jneuroinflammation.com/content/8/1/57
Page 3 of 10and anti-phospho-MAPKs. Subsequently, membranes
were incubated with secondary antibody streptavidin-
horseradish peroxidase conjugated affinity goat anti-rab-
bit IgG (Jackson, West Grove, PA, USA).
Statistical analysis
Data were expressed as the mean ± SD and mean ± SE,
in vivo and in vitro experiments, respectively. For single
variable comparisons, Student’s test was used. For multi-
ple variable comparisons, data were analyzed by one-way
analysis of variance (ANOVA) followed by Scheffe’s test
or the least significant differences post-hoc test. Catego-
rical variables were analyzed by use of Fisher’s exact
test, two-tailed Pearson’s chi-square test. Kendall’st a u - c
was used for testing a trend. P values less than 0.05
were considered significant.
Results
In vivo effect of sesamin extract on the KA-induced
oxidative stress
Treatment with sesamin extract (30 mg/kg) significantly
increased 50% and 55.8% of plasma a-tocopherol levels
from rats without and with KA treatment, compared to
the baseline level, respectively. In contrast, the plasma a-
tocopherol level did not change in vehicle control rats.
The TBARS level of the vehicle control group was 145% of
the naïve control animals. The TBARS level of the sesamin
(S-30) group was 117% of the naïve control and signifi-
cantly different from that of the vehicle control (V-30) (p
= 0.017). The sesamin treatment in SE mice increased the
SOD activity from 55% of the vehicle control mice to 81%
of sesamin-treated mice, respectively to the normal levels.
(p = 0.013). However at 15 mg/kg dosage of sesamin treat-
ment, neither TBARS nor SOD activity was different from
the vehicle control (V-15) (p > 0.05, Table 1).
Effect on mortality and behavior
Since the lower dosage of sesamin (15 mg/kg) did not
have a good antioxidant effect, we used the higher
dosage for the next experiment. The result showed that
treatment with sesamin extract (30 mg/kg) on the rats
with KA-induced SE decreased the mortality rate from
22% of the vehicle (V-30) group to 0% (p =0 . 0 4 9 ) .
However, sesamin extract did not significantly attenuate
the maximal seizure classes or the predominant beha-
vioral seizure patterns as compared with the vehicle (p
> 0.05, Tables 2 and 3). Nevertheless, there was a trend
of decreasing the clonic pattern of SE by sesamin treat-
ment that 8/23 (35%) in the vehicle (V-30) group
dropped to 3/22 (14%) in the sesamin (S-30) group
(Table 3).
In vitro protection of KA toxicity
KA can induce free radicals and damage neuronal cells,
therefore the cell viability and LDH released from PC12
cells were measured using MTT and LDH ELISA assays
[15]. As shown in Figure 1, PC12 cells were exposed to
150 μM KA for 24 h were protected by the presence of
sesamin (0.1, 0.5, 1.0, or 2.0 μM). KA-induced LDH
released was reduced and the cell viability was increased
by sesamin treatment. Similarly, BV-2 cells were pro-
tected by sesamin under KA stimulation (data not
shown).
KA-induced calcium release
KA triggers neurons membrane depolarization by the
release of calcium ions [18]. Our result showed that KA
induced calcium release from both PC12 and BV-2 cells
in a time-dependent manner and sesamin reduced the
calcium release more prominently from BV-2 cells than
from PC12 cells (Figure 2).
KA-induced ROS and lipid peroxidation
KA-treated PC12 cells or BV-2 cells increased DCF
fluorescence nearly one-fold after 120 min as compared
with the control cells. Sesamin protected cells against
KA-cytotoxicity by decreasing the ROS accumulation
(DCF signals) in both cells (Figure 3). Marked increase
Table 1 Effects of sesamin extract on TBARS (nmol/mg protein) and SOD (units/mg protein) in the mice with 2-h KA-
induced SE
Variable Vehicle Sesamin extract Naive P-value
a P-value
b
M ± SD M ± SD M ± SD (V, S) (V, N) (S, N)
15 mg/kg
TBARS 0.96 ± 0.22 0.85 ± 0.10 0.57 ± 0.04 0.001** 0.225 0.0002** 0.004**
SOD 4.18 ± 1.01 5.27 ± 2.01 8.79 ± 1.22 0.005** 0.686 0.003** 0.006**
30 mg/kg
TBARS 0.86 ± 0.14 0.69 ± 0.14 0.59 ± 0.06 0.003** 0.017* 0.001** 0.126
SOD 5.17 ± 1.90 7.54 ± 2.10 9.48 ± 1.17 0.0004** 0.013* 0.0001** 0.049*
M ± SD: mean ± standard deviation. N: naïve. S: sesamin extract. V: vehicle.
a One-way ANOVA test.
b Least significant differences post-hoc test. *P < 0.05, **P < 0.01.
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pared with the control cells (Figures 4-5). Treatment
with sesamin significantly reduced MDA levels as com-
pared to the KA-treated control (p < 0.01,).
Caspase-3 activation
Apoptotic signaling pathways were investigated in KA-
treated PC12 cells and BV-2 cells. The results showed
that KA increased Caspase-3 activation but sesamin
reduced the Caspase-3 expression dose-dependently in
both cells (Figure 6 and data not shown).
COX-2 and MAPK activation
Seizures, inflammation and apoptosis in neuronal cells
are known to be initiated with several signaling path-
ways such as MAPKs and Rho kinases [19-21]. There-
fore, the KA induced the activation of signaling
pathways were studied in PC12 cells and BV-2 cells for
M A Pk i n a s e s( J N K ,E R K ,p 3 8 ) ,R h o A ,a n dC O X - 2( F i g -
ure 6). We evaluated the effect of sesamin on KA-
induced pathways in PC12 cells at 10, 30, and 60 min
and in BV-2 cells 30, 60, 120 min by Western blot.
Western blot analysis revealed that sesamin (50 μM) sig-
nificantly reduced ERK1/2, p38 MAPKs and COX-2
expression in both cells and RhoA expression in BV-2
cells as compared to KA controls.
PGE2 production
We further evaluated whether the KA-induced COX-2
change would affect PGE2 production. The result
showed that sesamin reduced the PGE2 production in
both KA-induced PC12 cells and BV-2 cells as predicted
(Figure 7).
Discussion
The present result showed that sesamin protected ani-
mals from KA-induced brain injury. MDA and mortality
were significantly reduced as compared with the non-
treated one. The decreased mortality in the sesamin-
treated animals could also be confirmed by the sesamin
effect in vitro that showed a decreased LDH release and
Caspase-3 activation and increased cell viability in KA-
stimulated PC12 cells.
The neuroprotective effect of sesamin on KA-induced
injury was mainly due to its antioxidant effect on redu-
cing of MDA, the product of lipid peroxidation both in
vivo and in vitro. The antioxidant effect on reducing of
MDA could be attributed to the increased plasma a-
tocopherol level from the supplementation with sesamin
extract (Table 1). This is consistent with a study that
reports consumption of sesame seed powder over five
weeks increases plasma a-tocopherol levels in healthy
human volunteers [32]. KA administration is associated
with a depletion of ATP levels and accumulation of [Ca
2
+ ]i. PC12 cells treated with KA for 24 h reduced cell
viability dose-dependently by MTT assay. This was not
caused by changes in pH or osmotic pressure because
the inert mannitol at the concentration of 150 mM, did
not affect cell viability (data not shown). The increase in
[Ca
2+ ]i may trigger Ca
2+ -activated free radicals forma-
tion [33]. Sesamin decreased ROS and calcium release
from KA-treated PC12 cells and BV-2 cells. This agrees
with the earlier reports that antioxidants can protect
brain from KA-induced calcium ions and ROS release
[24-26]. It is also consistentw i t ht h es e s a m i na n t i o x i -
dant effect that protects hypoxia-or H2 O2 -induced
PC12 cell injury [22]. A study with defatted sesame
seeds extract (30, 100 and 300 mg/kg) given twice orally
at 0 h and 2 h after onset of ischemia shows the reduc-
tion of brain infarct volume dose-dependently and
improves sensory-motor function [34]. Thus, suppres-
sion of KA-induced ROS and Ca
2+ release by sesamin
was consistent with these notions. Since seizure can be
triggered by the KA-induced calcium ions release, the
decreased severity of seizure behavior could be partially
attributed to the sesamin antioxidative effect, although it
was not statistically significant due to the small sample
sizes
Since microglial activation as one mechanism by
which early-life seizures contribute to increased vulner-
ability to neurologic insults in adulthood, therapies that
Table 2 Effects of sesamin extract on the maximal seizure
class (MSC) and mortality rate of the rats with 5-h KA-
induced SE
Variables Control
(V-30)
n (%)
Sesamin
(S-30)
n (%)
P-value
Mortality 5 (22) 0 (0) 0.049
a
MSC
1-2 2 (9) 1 (4) 0.797
b
3-6 17 (74) 16 (73) 0.530
c
7-8 4 (17) 5 (23)
a Fisher’s exact test.
b Pearson’s chi-square test: all seizure classes were taken together.
c Kendall’s tau-c: all seizure classes were taken together.
S-30: sesamin extract (30 mg/kg). V-30: vehicle.
Table 3 The effect of sesamin extract on the
predominant behavior patterns of the rats with 5-h KA-
induced SE
Behavior Pattern Control
(V-30)
n (%)
Sesamin (S-30)
n (%)
P-value
Immobile or Exploratory 11 (48) 12 (54) 0.211
a
Masticatory 4 (17) 7 (32) 0.323
b
Clonic 8 (35) 3 (14)
a Pearson’s chi-square test: all behavioral patterns were taken together.
b Kendall’s tau-c: all behavioral patterns were taken together.
S-30: sesamin extract (30 mg/kg). V-30: vehicle.
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cial [35]. Present results showed that NO
. production in
KA-stimulated BV-2 cells was dose-dependently reduced
by sesamin and PGE2 production from both cells under
KA stress was also significantly reduced. This agrees
with other studies that sesamin protects PC12 cells from
MPP
+ -induced cellular death by increasing the SOD
activity and inducible nitric oxide synthase protein
(iNOS) expression and microglia from reducing interleu-
kin-6 (IL-6) mRNA levels [23]. We have reported pre-
viously that sesamin or sesamolin inhibits NO, iNOS,
tumor necrosis factor-a and IL-6 production in LPS-sti-
mulated BV-2 microglia [27]. In addition, sesamin and
sesamolin also reduced LPS-activated cytokine, p38
MAPK and NF-B activations [28].
The role of COX-2 mRNA and protein in KA-
induced brain injury has been reported [36-38]. The
KA-induced COX-2 expression parallels the appear-
ance of neuronal apoptotic features [36] and involves
with free radicals formation [39]. Several protease
families are implicated in apoptosis, the most promi-
nent being caspases [40]. We found that KA could
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Figure 1 Effect of sesamin on cell viability and cytotoxicity of kainic acid-stressed PC12 cells. Cells were treated with KA (150 μM) alone
or with various concentrations (0.1, 0.5, 1.0, 2.0 μM) of sesamin for 24 h. (A) LDH release was decreased and (B) cell viability increased by
sesamin.
* P < 0.01 as compared to KA control.
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Page 6 of 10affect the Caspase-3 activation in PC12 cells and BV-2
cells and sesamin could reduce both Caspase-3 expres-
sion. Since KA could induce the activation of MAP
kinases (JNK, ERK, p38), RhoA and COX-2 in PC12
cells, we found that sesamin suppressed KA-induced
COX-2, ERK, and p38 MAPK in PC12 cells and BV-2
cells. Our result is similar to a study of tea extract
(TF3) treatment that shows TF3 reduces the gene and
protein expression of COX-2 and iNOS, and NF-B
activation from cerebral ischemia-reperfusion [41].
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alone or with various sesamin concentrations (0.1-2.0 μM) of
sesamin for 24 h. Treatment with sesamin effectively reduced the
release of Ca
2+ under KA stress.
* P < 0.01 as compared to the KA
control.
(A)
(B)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
control
KA 150 uM
KA 150 uM + SA 0.1 uM
KA 150 uM + SA 0.5 uM
KA 150 uM + SA 1 uM
KA 150 uM + SA 2 uM
0 30  60    90    120  (min)
PC12
R
O
S
 
(
n
M
 
D
C
F
)
 
0.35
0.40
0.45
0.50
0.55
0.60
0.65
0.70
0.75
Control 
KA150uM 
KA150uM+SA10uM
R
O
S
 
(
n
M
 
D
C
F
)
 
0       3 0        6 0       9 0       1 2 0  (min)
BV-2 
Figure 3 Effect of sesamin on ROS accumulation in PC12 cells
and BV-2 cells under KA stress. Sesamin effectively reduced the
ROS production from (PC12 cells induced by KA stress (150 μM) at
120-min.
* P < 0.01 as compared to the KA control.
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Figure 4 Effect of sesamin on lipid peroxidation of PC12 cells
under KA stress. Lipid peroxidation (LPO) was determined by a
LPO assay kit (Cayman Chemical, Ann Arbor, MI, USA).
Malondialdehyde (MDA) of PC12 cells was induced by 24-h KA
stress (150 μM) and effectively reduced by sesamin.
* P < 0.01 as
compared to the KA control.
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Page 7 of 10However, KA-induced RhoA pathway in BV-2 cells but
not PC12 cells was reduced by sesamin.
Our data also showed that sesamin extract had the ten-
d e n c yt od e c r e a s et h es e v e r i t yo fs e i z u r eb e h a v i o r .A
recent study indicated the lack of effectiveness of antioxi-
dants in the kainic acid SE model [42]. However, antioxi-
dants had significant anticonvulsant activity against
pilocarpine. This discrepancy could be explained by the
fact that KA is a glutamate receptor agonist while pilo-
carpine is a muscarinic agonist [43]. Because of the small
number of animals in our study, the ameliorating effect
of sesamin extract on behavioral severity was not statisti-
cally significant. Further studies are needed to confirm
whether sesamin has direct effects on the seizure beha-
vior and the related molecular mechanism in this issue.
The present results are consistent with previous reports
that antioxidants such as resveratrol, vitamin-E, melato-
nin, and lipoic acids are also protective against various
animal models of SE in terms of the oxidative stress or
convulsions [44-51]. Particularly, resveratrol protects
against KA-induced neuronal damage [7,10,14,49]. How-
ever, in the present study the concentrations of sesamin
likely to be achieved in vivo were too low to act as chain-
breaking antioxidants. Only higher dose (30 mg/kg) of
sesamin supplementation significantly increased plasma
a-tocopherol level and reduced the TBARS level as com-
pared with the vehicle control rats. It is more likely that
sesamin acts as a pharmacological antioxidant by block-
ing enzymes or pathways of neuroinflammation that
would produce ROS/RNS.
Stopping the seizure activity earlier is the best way to
prevent SE-induced free radicals and neuronal damage.
However, clinical experience shows that SE can be
refractory to the commonly used medications. There-
fore, intervention by antioxidants can be a potential
beneficial approach in the treatment of SE.
Conclusion
Sesamin ameliorates oxidative stress in KA-induced sta-
tus epilepticus and warrants further study for the mole-
cular mechanism.
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Figure 6 Effect of sesamin on MAP kinases, RhoA and COX-2
activation in PC12 cells and BV-2 cells under KA stress. The
effect of sesamin (1-50 μM) on KA-activated cell signaling pathways
was determined by Western blotting under KA stress, (A) PC12 cells
for 10-min and 60-min and (B) BV-2 cells for 120 min. Sesamin
effectively reduced the activation of COX-2, ERK, p38 MAP kinases.
*
P < 0.01 as compared to the KA control. CK: normal control.
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(COX-2) Cyclooxygenase-2, (DCF) dichlorofluorescein, (DMEM) Dulbecco’s
modified Eagle’s medium, (FBS) fetal bovine serum, (H2 DCF-DA) 2’,7’-
dichlorodihydrofluorescein diacetate, (HBSS) Hank’s balanced salt solution,
(IL-6) interleukin-6, (iNOS) Inducible-nitric oxide synthase, (KA) Kainic acid,
(LDH) Lactate dehydrogenase, (LPO) lipid peroxidation, (LPS)
Lipopolysaccharide, (MDA) Malondialdehyde, (MAPKs) Mitogen-activated
protein kinases, (MPP
+) 1-methyl-4-phenyl-pyridine, (MTT) 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyl tetrazolium bromide, (NADH) nicotinamide adenine
dinucleotide, (NF-κB) Nuclear factor-κB, (NO) Nitric oxide, (PBS) Phosphate-
buffered saline, (PC12 cells) Pheochromacytoma, (PGE2) Prostaglandin E2,
(ROS) Reactive oxygen species, (SE) Status epilepticus, (SOD) Superoxide
dismutase, (TBARS) thiobarbituric acid reacting substances.
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